fda reconsiders tirzepatide confirms shortage is still over, gives compounders a grace period FDA Allows Compounded Tirzepatide During

Patients have found the medications to be life-changing in ways both positive and negative.

Wegovy, however, is the first weekly injectable treatment in South Africa that is specifically registered and approved for weight management.

Discover the safety of combining tirzepatide with antidepressants, potential interactions, and what to discuss with your healthcare provider.

In addition, there will be a $350 million up-front payment as Abbvie takes over the reins of GUB-014295 (referred to as Gubamy), a long-acting analog of the satiety hormone amylin, currently in phase I development.

Managing weight while living with ulcerative colitis requires careful medication selection

Semaglutide has recently been approved for weight loss in patients